ARTICLE | Company News
AVI BioPharma and DepoMed delivery deal
June 19, 2000 7:00 AM UTC
AVII and DMI will assess the feasibility of delivering orally one or more of AVII's Neugene antisense compounds using DMI's Gastric Retention controlled release system to deliver drugs to the upper ga...